BCO trades 66.9% below Wall Street's consensus target of $163.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes BCO achieves its forward estimates and maintains a stable P/E multiple of 10.6x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, The Brink's Company (BCO) has a Wall Street consensus price target of $163.00, based on estimates from 9 covering analysts. With the stock currently trading at $97.67, this represents a potential upside of +66.9%. The company has a market capitalization of $4.02B.
Analyst price targets range from a low of $163.00 to a high of $163.00, representing a 0% spread in expectations. The median target of $163.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BCO trades at a trailing P/E of 20.8x and forward P/E of 10.6x. The forward PEG ratio of 0.18 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +112.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $127.46, with bear and bull scenarios of $80.30 and $167.94 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ARMKAramark | $14.0B | $53.32 | $55.25 | +3.6% | Buy | 23.7x | 24 |
ABMABM Industries Incorporated | $2.6B | $44.15 | $48.33 | +9.5% | Hold | 11.1x | 11 |
ALLEAllegion plc | $11.5B | $133.57 | $162.33 | +21.5% | Hold | 15.2x | 23 |
CTASCintas Corporation | $68.8B | $170.85 | $241.00 | +41.1% | Hold | 34.9x | 30 |
DBDDiebold Nixdorf, Incorporated | $2.9B | $83.81 | $100.00 | +19.3% | Buy | 15.3x | 13 |
NATLNCR Atleos Corporation | $3.2B | $43.63 | $50.40 | +15.5% | Hold | 10.4x | 4 |
VRRMVerra Mobility Corporation | $674M | $4.44 | $5.75 | +29.5% | Hold | 3.6x | 12 |
BACBank of America Corporation | $424.1B | $56.20 | $61.13 | +8.8% | Buy | 12.6x | 54 |
WFCWells Fargo & Company | $264.5B | $82.21 | $99.38 | +20.9% | Hold | 11.7x | 60 |
SWKStanley Black & Decker, Inc. | $13.5B | $86.75 | $88.67 | +2.2% | Hold | 19.1x | 37 |
Quick answers to the most common questions about buying BCO stock.
The consensus Wall Street price target for BCO is $163, representing 66.9% upside from the current price of $97.67. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BCO has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $163 implies 66.9% upside from current levels.
With a forward P/E of 10.5703x, BCO trades at a relatively low valuation. The consensus target of $163 implies 66.9% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $163 for BCO, while the most conservative target is $163. The consensus of $163 represents the median expectation. Our quantitative valuation model projects a bull case target of $168 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
BCO is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BCO stock forecast based on 9 Wall Street analysts shows a consensus price target of $163, with estimates ranging from $163 (bear case) to $163 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $127, with bear/bull scenarios of $80/$168.
Our quantitative valuation model calculates BCO's fair value at $127 (base case), with a bear case of $80 and bull case of $168. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
BCO trades at a forward P/E ratio of 10.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on BCO, with a "Buy" consensus rating and $163 price target (66.9% upside). 6 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BCO analyst price targets range from $163 to $163, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $163 consensus represents the middle ground. Our model's $80-$168 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.